Developments in Phenotypic Precision Medicine for Prostate Cancer

Developments in Phenotypic Precision Medicine for Prostate Cancer

Stanford Cancer Institute Breakthroughs in Cancer: Luis Diaz, MDПодробнее

Stanford Cancer Institute Breakthroughs in Cancer: Luis Diaz, MD

New Research in Phenotypic Precision MedicineПодробнее

New Research in Phenotypic Precision Medicine

The Current Landscape of Phenotypic Precision Medicine for Advanced Prostate CancerПодробнее

The Current Landscape of Phenotypic Precision Medicine for Advanced Prostate Cancer

Evan Ya-Wen Yu, M.D. on Phenotypic Precision Medicine and its Role in GU Oncology - Part 2Подробнее

Evan Ya-Wen Yu, M.D. on Phenotypic Precision Medicine and its Role in GU Oncology - Part 2

Challenges & Advances in Phenotypic Precision MedicineПодробнее

Challenges & Advances in Phenotypic Precision Medicine

Dr. Daniel Spratt Discusses Phenotypic Precision Medicine in Advanced Prostate CancerПодробнее

Dr. Daniel Spratt Discusses Phenotypic Precision Medicine in Advanced Prostate Cancer

Dr. Dan George, Duke Health, on Phenotypic Precision Medicine in Prostate CancerПодробнее

Dr. Dan George, Duke Health, on Phenotypic Precision Medicine in Prostate Cancer

Towards Metformin RepurposingПодробнее

Towards Metformin Repurposing

Evan Ya-Wen Yu, M.D. on Phenotypic Precision Medicine and its Role in GU Oncology - Part 1Подробнее

Evan Ya-Wen Yu, M.D. on Phenotypic Precision Medicine and its Role in GU Oncology - Part 1

PSMA: Current State of the Art and Future VisionПодробнее

PSMA: Current State of the Art and Future Vision